Access longitudinal, consented, patient-level data with full provenance. Stress-test compounds with AI-driven digital twins and cut discovery time with advanced cohort analytics.
BlockMed Pro connects you directly to patients who have chosen to share their longitudinal health data, eliminating broker mark-up and giving you provenance you can trust all the way back to source.
Combine primary-care records, wearable telemetry and AI digital-twin simulation in one compliant platform.
Everything you need to move from raw real-world data to research-ready insight.
Granular, longitudinal patient-level data with full blockchain-backed provenance and immutability.
Stress-test compounds using AI-powered patient simulations before committing to costly trials.
Natural-language cohort queries and predictive modelling, surfacing insight without exposing methodology.
A clear delivery path through 2026 and into decentralised trials.
AI Query Engine v1 with natural-language queries
Analytics dashboards & RWE visualisations
Predictive models & AI query-credits system
Dynamic longitudinal datasets & advanced analytics
Decentralised trials platform for real-time engagement
Five reasons global pharma teams are choosing BlockMed Pro for real-world evidence.
Direct-to-patient model eliminates broker mark-up.
Rich telemetry from wearables and real-time EHR feeds.
Ethical, consented data with full audit trails.
Digital twin functionality for compound stress-testing.
One platform uniting patient autonomy, AI analytics and blockchain security.
We build bespoke data-access packages around your therapeutic area and research questions, from targeted cohort extracts to enterprise-wide longitudinal access. Pricing is tailored to scope.
Enquire about enterprise access →Tell us about your therapeutic area and research goals. We'll show you how consented real-world data and digital-twin modelling can de-risk and speed up your discovery programme.